- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.02. | 'Hypertension Bites': AstraZeneca-backed coalition launches '90s-inspired awareness campaign | ||
| 17.02. | Ocular Therapeutix eyes FDA filing with ph. 3 wet AMD win over Eylea, but investors balk | ||
| 17.02. | Lilly's rare cancer drug Retevmo looks to broaden reach with adjuvant trial win | ||
| 17.02. | Roche adds to Gazyva's growing autoimmune pedigree with new phase 3 kidney condition win | ||
| 17.02. | Sanofi bids adieu to specialty care chief, promotes Manuela Buxo to assume key post | ||
| 17.02. | Novartis taps Niowave for long-term supply of radiopharmaceutical isotope | ||
| 13.02. | Lilly's pre-launch inventory of oral GLP-1 candidate swells ahead of expected FDA obesity nod | ||
| 13.02. | Astellas casts retina specialists as 'Partners in Protection' in Izervay HCP campaign | ||
| 13.02. | Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year | ||
| 13.02. | With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment | ||
| 13.02. | Bayer and celebrity chef keep diners in the dark to shed light on heart health | ||
| 13.02. | Novartis to seek full FDA approval for IgAN drug Vanrafia despite missing ph. 3 kidney function goal | ||
| 13.02. | PTC shuts down FDA approval bid for troubled Duchenne med Translarna | ||
| 12.02. | Amid Wegovy pill's flying start in US, Novo CEO eyes Ireland expansion for supply overseas: Bloomberg | ||
| 12.02. | AbbVie mounts fresh IRA legal challenge over Botox's inclusion in latest drug pricing negotiations list | ||
| 12.02. | Alnylam turns profitable even as Amvuttra ATTR revenue disappoints in Q4 | ||
| 12.02. | Supreme seasons creative agency portfolio with Broth buyout | ||
| 12.02. | CSL's bleak earnings report helps explain why it made CEO switch | ||
| 12.02. | Sanofi ousts Paul Hudson after 'bumpy ride', poaches Merck KGaA CEO to lead the French pharma | ||
| 11.02. | J&J's Tremfya roars into 2026 with massive TV ad spend, trailed by AbbVie's Rinvoq and Skyrizi | ||
| 11.02. | GSK, Teva quietly settle Coreg 'skinny label' dispute after long legal back-and-forth | ||
| 11.02. | Despite tempered sales outlook, Gilead positions Yeztugo to dominate HIV PrEP market as sales surge for older Descovy | ||
| 11.02. | China indicts AstraZeneca and former exec Leon Wang over data, trade charges | ||
| 11.02. | Merck pushes Keytruda across the FDA finish line for its first ovarian cancer nod | ||
| 10.02. | NIH stops Xarelto arm of stroke trial due to safety, lack of efficacy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.